Does Zepbound Affect Vitamin B12 Absorption?
No, there is no evidence that tirzepatide (Zepbound) directly affects vitamin B12 absorption. The FDA-approved drug label does not list vitamin B12 deficiency as a known adverse effect, and systematic analysis of the SURMOUNT clinical trials found no clinically significant impact on nutritional status 1, 2.
Evidence from Clinical Trials
The most comprehensive data comes from a post hoc analysis of the SURMOUNT-1-4 trials involving 4,726 participants treated with tirzepatide. Vitamin deficiency-related adverse events occurred in 0.99% of tirzepatide-treated participants compared to 1.07% of placebo-treated participants—essentially no difference 2. This analysis specifically examined nutritional outcomes and found:
- Macronutrient malnutrition events were extremely rare (0.03-0.06% incidence)
- Treatment discontinuations due to nutritional concerns occurred in only 0.53% of participants
- No systematic pattern of vitamin deficiencies emerged
Important Distinction from Metformin
This contrasts sharply with metformin, which has well-established effects on vitamin B12 status. Metformin reduces serum B12 levels by 22-29% and increases the risk of deficiency, particularly with long-term use 3. Tirzepatide does not share this mechanism or risk profile.
Clinical Implications
While tirzepatide itself doesn't affect B12 absorption, you should still consider B12 monitoring in patients who:
- Have pre-existing risk factors for B12 deficiency (vegan diet, gastric conditions, concurrent metformin use, history of bariatric surgery) 4
- Experience significant weight loss that may be accompanied by dietary restriction
- Develop neurological symptoms (peripheral neuropathy, cognitive changes, balance issues) or hematologic abnormalities (macrocytic anemia) 4
Key Caveat About Compounded Products
If your patient is using compounded tirzepatide/B12 combinations rather than FDA-approved Zepbound, be aware that these products contain a novel chemical impurity formed by the reaction between tirzepatide and certain B12 analogs 5. The clinical significance of this impurity is unknown, and these compounded products undergo no FDA evaluation for safety or efficacy.
Bottom Line
Monitor B12 status based on patient-specific risk factors, not because of tirzepatide itself. Use active B12 (holotranscobalamin) or total B12 testing when clinical suspicion arises from symptoms or pre-existing risk factors 4. The medication does not require routine B12 monitoring in otherwise low-risk patients.